中国癌症相关性疲乏临床实践诊疗指南（2021年版）

[1] 恶性肿瘤患者的癌因性疲乏中医证型临床研究.[D].张永慧.广州中医药大学.2015, 12

[2] Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment [J]. ANNALS OF ONCOLOGY, 2020, 31 (06) : 713 - 723

[3] Clinical response and safety of apatinib monotherapy in recurrent, metastatic cervical cancer after failure of chemotherapy: a retrospective study [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (01)

[4] Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study.[J].A. Le Cesne;P. Marec-Berard;J.-Y. Blay;N. Gaspar;F. Bertucci;N. Penel;E. Bompas;S. Cousin;M. Toulmonde;A. Bessede;W.H. Fridman;C. Sautes-Fridman;M. Kind;F. Le Loarer;M. Pulido;A. Italiano.European Journal of Cancer.2019,

[5] Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study [J]. CANCER, 2019, 125 (13) : 2291 - 2299

[6] Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO) [J]. SUPPORTIVE CARE IN CANCER, 2019, 27 (03) : 1041 - 1047

[7] Qualitative and Quantitative Assessment of Patient and Carer Experience of Chemotherapy (Docetaxel) in Combination with Androgen Deprivation Therapy (ADT) for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) [J]. ADVANCES IN THERAPY, 2018, 35 (12) : 2186 - 2200

[8] The Physical Activity Guidelines for Americans [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (19): : 2020 - 2028

[9] Fatigue After Breast Cancer Treatment: Biobehavioral Predictors of Fatigue Trajectories [J]. HEALTH PSYCHOLOGY, 2018, 37 (11) : 1025 - 1034

[10] Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors.[J].Huijuan Mao;Ting Bao;Xueyong Shen;Qing Li;Christina Seluzicki;Eun-Ok Im;Jun J. Mao.European Journal of Cancer.2018,

[1] 恶性肿瘤患者的癌因性疲乏中医证型临床研究.[D].张永慧.广州中医药大学.2015, 12

[2] Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment [J]. ANNALS OF ONCOLOGY, 2020, 31 (06) : 713 - 723

[3] Clinical response and safety of apatinib monotherapy in recurrent, metastatic cervical cancer after failure of chemotherapy: a retrospective study [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (01)

[4] Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study.[J].A. Le Cesne;P. Marec-Berard;J.-Y. Blay;N. Gaspar;F. Bertucci;N. Penel;E. Bompas;S. Cousin;M. Toulmonde;A. Bessede;W.H. Fridman;C. Sautes-Fridman;M. Kind;F. Le Loarer;M. Pulido;A. Italiano.European Journal of Cancer.2019,

[5] Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study [J]. CANCER, 2019, 125 (13) : 2291 - 2299

[6] Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO) [J]. SUPPORTIVE CARE IN CANCER, 2019, 27 (03) : 1041 - 1047

[7] Qualitative and Quantitative Assessment of Patient and Carer Experience of Chemotherapy (Docetaxel) in Combination with Androgen Deprivation Therapy (ADT) for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) [J]. ADVANCES IN THERAPY, 2018, 35 (12) : 2186 - 2200

[8] The Physical Activity Guidelines for Americans [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (19): : 2020 - 2028

[9] Fatigue After Breast Cancer Treatment: Biobehavioral Predictors of Fatigue Trajectories [J]. HEALTH PSYCHOLOGY, 2018, 37 (11) : 1025 - 1034

[10] Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors.[J].Huijuan Mao;Ting Bao;Xueyong Shen;Qing Li;Christina Seluzicki;Eun-Ok Im;Jun J. Mao.European Journal of Cancer.2018,